P. Allard

发表

Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea

A. Kopp-Schneider, A. Kulozik, H. Cario, 2021, Haematologica.

P53 point mutations in initial superficial bladder cancer occur only in tumors from current or recent cigarette smokers.

B. Têtu, L. Moore, F. Meyer, 2000, Carcinogenesis.

The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index.

B. Têtu, Y. Fradet, P. Allard, 1998, British journal of urology.

Anesthetic and surgical complications in 219 cases of myotonic dystrophy

P. Bégin, J. Mathieu, P. Allard, 1997, Neurology.

Epidemiological Study of Ruptured Intracranial Aneurysms in the Saguenay-Lac-Saint-Jean region (Quebec, Canada)

L. Pérusse, P. Allard, C. Prévost, 1996, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Failure of the perioperative PCV neoadjuvant polychemotherapy in resectable bronchogenic non‐small cell carcinoma results from a randomized phase II trial

J. Benichou, B. Dautzenberg, C. Chastang, 1990, Cancer.

Total and specific immunoglobulin E and their relationship to respiratory symptoms in Quebéc children and adolescents.

S. Gingras, P. Ernst, Jacinthe Aubin, 2005, Canadian respiratory journal.

Tumor-associated antigens as prognostic factors for recurrence in 382 patients with primary transitional cell carcinoma of the bladder.

B. Têtu, Y. Fradet, P. Allard, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence.

L. Lacombe, B. Têtu, L. Moore, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Prognostic significance of nuclear DNA content and S-phase fraction by flow cytometry in primary papillary superficial bladder cancer.

Y. Fradet, P. Allard, P. Bernard, 1996, Human pathology.

Prevalence and Clinical Significance of Her-2/neu, p53 and Rb Expression in Primary Superficial Bladder Cancer

Y. Fradet, P. Allard, P. Bernard, 1996 .

The incidence and carrier frequency of Tay‐Sachs disease in the French‐Canadian population of Quebec based on retrospective data from 24 years, 1992–2015

J. Rivière, P. Allard, G. Sillon, 2020, Journal of genetic counseling.

Six vs twelve cycles for complete responders to chemotherapy in small cell lung cancer: definitive results of a randomized clinical trial. The "Petites Cellules" Group.

C. Chastang, P. Allard, B. Lebeau, 1992, The European respiratory journal.

A 10-year study of mortality in a cohort of patients with myotonic dystrophy

L. Potvin, P. Bégin, J. Mathieu, 1999, Neurology.

[Duckett's+ simple surface or double surface? Comparison of 2 urethroplasty procedures. Report of 91 hypospadias].

P. Allard, P. Vergnes, J. Bondonny, 1993, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Sensitivity and specificity of computed tomography for the detection of adrenal metastatic lesions among 91 autopsied lung cancer patients

B. Yankaskas, R. Fletcher, R. Halvorsen, 1990, Cancer.

Prevalence and clinical significance of HER/2neu, p53 and Rb expression in primary superficial bladder cancer.

Y. Fradet, P. Allard, P. Bernard, 1996, The Journal of urology.

Ileocolonic Anastomosis by Biofragmentable Ring for Bladder Substitution

J. Ferrière, P. Allard, J. Maire, 1995 .

Adult-onset painful axonal polyneuropathy caused by a dominant NAGLU mutation.

B. Brais, K. Gehring, Michael A. Gonzalez, 2015, Brain : a journal of neurology.